127 related articles for article (PubMed ID: 37671907)
1. Degradation of Cyclin-Dependent Kinase 9/Cyclin T1 by Optimized Microtubule-Associated Protein 1 Light Chain 3 Beta-Recruiting Coumarin Analogs.
Zeng Y; Xiao J; Xu Y; Wei F; Tian L; Gao Y; Chen Y; Hu Y
J Med Chem; 2023 Sep; 66(18):12877-12893. PubMed ID: 37671907
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Small-Molecule Degraders of the CDK9-Cyclin T1 Complex for Targeting Transcriptional Addiction in Prostate Cancer.
Li J; Liu T; Song Y; Wang M; Liu L; Zhu H; Li Q; Lin J; Jiang H; Chen K; Zhao K; Wang M; Zhou H; Lin H; Luo C
J Med Chem; 2022 Aug; 65(16):11034-11057. PubMed ID: 35925880
[TBL] [Abstract][Full Text] [Related]
3. Discovery of HyT-Based Degraders of CDK9-Cyclin T1 Complex.
Lin R; Yang J; Liu T; Wang M; Ke C; Luo C; Lin J; Li J; Lin H
Chem Biodivers; 2023 Aug; 20(8):e202300769. PubMed ID: 37349855
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation.
Olson CM; Jiang B; Erb MA; Liang Y; Doctor ZM; Zhang Z; Zhang T; Kwiatkowski N; Boukhali M; Green JL; Haas W; Nomanbhoy T; Fischer ES; Young RA; Bradner JE; Winter GE; Gray NS
Nat Chem Biol; 2018 Feb; 14(2):163-170. PubMed ID: 29251720
[TBL] [Abstract][Full Text] [Related]
5. Discovery of selective CDK9 degraders with enhancing antiproliferative activity through PROTAC conversion.
Qiu X; Li Y; Yu B; Ren J; Huang H; Wang M; Ding H; Li Z; Wang J; Bian J
Eur J Med Chem; 2021 Feb; 211():113091. PubMed ID: 33338869
[TBL] [Abstract][Full Text] [Related]
6. Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome.
Kiernan RE; Emiliani S; Nakayama K; Castro A; Labbé JC; Lorca T; Nakayama Ki K; Benkirane M
Mol Cell Biol; 2001 Dec; 21(23):7956-70. PubMed ID: 11689688
[TBL] [Abstract][Full Text] [Related]
7. Discovery of coumarin derivatives as potent and selective cyclin-dependent kinase 9 (CDK9) inhibitors with high antitumour activity.
Xu J; Li H; Wang X; Huang J; Li S; Liu C; Dong R; Zhu G; Duan C; Jiang F; Zhang Y; Zhu Y; Zhang T; Chen Y; Tang W; Lu T
Eur J Med Chem; 2020 Aug; 200():112424. PubMed ID: 32447197
[TBL] [Abstract][Full Text] [Related]
8. The CDK9-cyclin T1 complex mediates saturated fatty acid-induced vascular calcification by inducing expression of the transcription factor CHOP.
Shiozaki Y; Okamura K; Kohno S; Keenan AL; Williams K; Zhao X; Chick WS; Miyazaki-Anzai S; Miyazaki M
J Biol Chem; 2018 Nov; 293(44):17008-17020. PubMed ID: 30209133
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Wogonin-based PROTACs against CDK9 and capable of achieving antitumor activity.
Bian J; Ren J; Li Y; Wang J; Xu X; Feng Y; Tang H; Wang Y; Li Z
Bioorg Chem; 2018 Dec; 81():373-381. PubMed ID: 30196207
[TBL] [Abstract][Full Text] [Related]
10. Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer.
Noblejas-López MDM; Gandullo-Sánchez L; Galán-Moya EM; López-Rosa R; Tébar-García D; Nieto-Jiménez C; Gómez-Juárez M; Burgos M; Pandiella A; Ocaña A
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628286
[TBL] [Abstract][Full Text] [Related]
11. TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1/β-catenin degradation and is targeted for GSK3B/GSK3β-mediated phosphorylation and degradation.
Wu H; Lu XX; Wang JR; Yang TY; Li XM; He XS; Li Y; Ye WL; Wu Y; Gan WJ; Guo PD; Li JM
Autophagy; 2019 Sep; 15(9):1506-1522. PubMed ID: 30806153
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo.
Majello B; Napolitano G; Giordano A; Lania L
Oncogene; 1999 Aug; 18(32):4598-605. PubMed ID: 10467404
[TBL] [Abstract][Full Text] [Related]
13. Bifunctional degraders of cyclin dependent kinase 9 (CDK9): Probing the relationship between linker length, properties, and selective protein degradation.
Tokarski RJ; Sharpe CM; Huntsman AC; Mize BK; Ayinde OR; Stahl EH; Lerma JR; Reed A; Carmichael B; Muthusamy N; Byrd JC; Fuchs JR
Eur J Med Chem; 2023 Jun; 254():115342. PubMed ID: 37071962
[TBL] [Abstract][Full Text] [Related]
14. HYPK coordinates degradation of polyneddylated proteins by autophagy.
Ghosh DK; Ranjan A
Autophagy; 2022 Aug; 18(8):1763-1784. PubMed ID: 34836490
[TBL] [Abstract][Full Text] [Related]
15. Recruitment of cyclin-dependent kinase 9 to nuclear compartments during cytomegalovirus late replication: importance of an interaction between viral pUL69 and cyclin T1.
Feichtinger S; Stamminger T; Müller R; Graf L; Klebl B; Eickhoff J; Marschall M
J Gen Virol; 2011 Jul; 92(Pt 7):1519-1531. PubMed ID: 21450947
[TBL] [Abstract][Full Text] [Related]
16. In silico design of small molecule inhibitors of CDK9/cyclin T1 interaction.
Randjelovic J; Eric S; Savic V
J Mol Graph Model; 2014 May; 50():100-12. PubMed ID: 24769691
[TBL] [Abstract][Full Text] [Related]
17. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription.
O'Keeffe B; Fong Y; Chen D; Zhou S; Zhou Q
J Biol Chem; 2000 Jan; 275(1):279-87. PubMed ID: 10617616
[TBL] [Abstract][Full Text] [Related]
18. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
[TBL] [Abstract][Full Text] [Related]
19. Computational study and peptide inhibitors design for the CDK9 - cyclin T1 complex.
Randjelović J; Erić S; Savić V
J Mol Model; 2013 Apr; 19(4):1711-25. PubMed ID: 23296566
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Potent and Selective CDK9 Degraders for Targeting Transcription Regulation in Triple-Negative Breast Cancer.
Wei D; Wang H; Zeng Q; Wang W; Hao B; Feng X; Wang P; Song N; Kan W; Huang G; Zhou X; Tan M; Zhou Y; Huang R; Li J; Chen XH
J Med Chem; 2021 Oct; 64(19):14822-14847. PubMed ID: 34538051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
